Cross-linked hyaluronic acid dermal filler for lip enhancement
Certifications
Manufactured by Prollenium Medical Technologies Inc. under medical device quality standards; marketed as CE Marked hyaluronic acid dermal filler (non Medicinal injectable device).
Restricted to use by licensed medical professionals; sale or administration only under prescription/order by qualified practitioners.
Biodegradable and hyaluronidase Reversible — in case of adverse effect or unsatisfactory aesthetic outcome, filler may be dissolved under medical supervision.
Manufactured by Prollenium Medical Technologies Inc. under medical device quality standards; marketed as CE Marked hyaluronic acid dermal filler (non Medicinal injectable device).
Restricted to use by licensed medical professionals; sale or administration only under prescription/order by qualified practitioners.
Biodegradable and hyaluronidase Reversible — in case of adverse effect or unsatisfactory aesthetic outcome, filler may be dissolved under medical supervision.
Cross-linked hyaluronic acid dermal filler for lip enhancement
Description
Revanesse Kiss+ with Lidocaine is a sterile, cross-linked hyaluronic acid (HA) gel dermal filler designed for lip augmentation, contouring and perioral rejuvenation. The product uses proprietary Thixofix® cross-linking technology to deliver a smooth, malleable gel with optimal cohesivity and shape retention, providing natural-looking, soft lip volume and definition. It is supplied in a pack containing two prefilled 1.2 ml syringes plus sterile needles; the gel is intended for injection by qualified medical professionals only.
Bnefits
Specifically formulated for lip and perioral enhancement — volume, shape and definition with a natural feel.
Smooth, monophasic HA gel with high concentration and good cohesivity for even distribution and soft, natural results.
Includes lidocaine (0.3% w/w) to minimise injection pain and improve patient comfort.
Reduced risk of swelling and inflammation compared to some other fillers, due to smooth gel particles and optimized rheology.
Biocompatible, biodegradable HA-based filler that can be dissolved with hyaluronidase if needed.
Indications
Lip augmentation — increasing lip volume and enhancing lip shape and definition.
Perioral rejuvenation — smoothing fine lines around the mouth and relaxing ‘smoker’s lines’ / perioral wrinkles.
Volume correction or augmentation of lip vermilion and border, symmetry correction, and soft tissue enhancement in the perioral region.
Monophasic, cross-linked HA gel, sterile, viscoelastic, colourless and clear.
Supplied in sterile, single-use, prefilled disposable glass syringes (2 × 1.2 ml) with sterile needles (27G or 30G) included.
Packaging
Box containing two prefilled glass syringes of 1.2 ml HA gel each.
Includes two sterile 27G (or 30G) needles for immediate use.
Syringes are individually sealed in sterile trays/blisters; outer carton labelled with batch number, expiry date, product information and instructions for use.
Usage
Must be administered only by trained and licensed medical professionals experienced in facial injectable procedures.
Prior to injection, perform full medical history, informed consent and assessment of suitability, including risk of allergies to lidocaine or HA components.
Prepare and disinfect the injection site; attach a sterile 27G or 30G needle to syringe, expel air bubbles, and prime the filler carefully.
Inject into submucosal or superficial dermal layers of the lip vermilion or border, using small bolus or linear threading technique as per clinician’s standard of care for lip augmentation.
Massage gently after injection for even distribution if needed; avoid overcorrection.
Advise patient to follow post-treatment care: avoid makeup on treated area for recommended period, avoid intense heat or cold, strenuous exercise, alcohol or lip massage for 24–48 hours (or per clinician protocol).
Store unused syringes in original sealed packaging until use; do not reuse syringe or needle — single-use only.
Contraindications
Known hypersensitivity or allergy to hyaluronic acid, lidocaine or any filler components (e.g. BDDE or preservation agents).
Active infection, inflammation, open wounds, acne or other dermatological conditions on or near the injection site (e.g. perioral area, lips).
History of severe allergic or anaphylactic reactions to injectable fillers or local anaesthetics (amide-type).
Bleeding disorders, anticoagulant or antiplatelet therapy, or other conditions increasing bleeding risk, unless judged safe by clinician.
Pregnant or breastfeeding women (safety not established).
Patients under the legal age for aesthetic injectable treatments per local regulations (commonly under 18 or 21 depending on region).
Adverse Effects
Common, usually temporary injection-site reactions including redness, swelling, bruising, tenderness, pain, itching or mild discomfort.
Risk of lumps, nodules or unevenness if filler is over-injected or poorly distributed; may resolve spontaneously or require correction.
Allergic or hypersensitivity reactions to HA, lidocaine or other components, potentially including delayed inflammatory reactions or granuloma formation.
Infection if aseptic technique is not strictly followed or aftercare instructions are ignored.
Rare vascular complications (e.g. intravascular injection, occlusion, tissue ischaemia, necrosis) if injected incorrectly — especially in lip vascular anatomy.
Temporary numbness or altered sensation related to lidocaine or injection trauma, possibly transient.
Storage Conditions
Store unopened syringes at controlled room temperature as specified in product packaging (commonly between 2°C and 25°C); do not freeze.
Keep syringes in original sealed packaging, away from direct sunlight and extreme heat or cold, until use.
Use each syringe only once — dispose of any unused product, needles and syringes after treatment as per clinical waste regulations.
Do not use if outer packaging is damaged, seal is broken, product appears discoloured or contains particulate matter.
Duration
Effects typically last between 6 and 12 months, depending on patient metabolism, lifestyle and injection technique; some patients may seek touch-up or repeat treatments after this period.
Onset
Initial lip fullness and volume are visible immediately after injection; final settled result is generally apparent within 1\u20132 weeks as swelling subsides.
